|
|
Investigation of the impact of HLA-DPB1 matching status in 10/10 HLA matched unrelated hematopoietic stem cell transplantation: Results of a French single center study
Cyrille Touzeau
,
Katia Gagne
,
Véronique Sébille
,
Patricia Herry
,
Patrice Chevallier
,
et al.
Journal articles
inserm-03349763v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma
Christelle Dousset
,
Sophie Maïga
,
Patricia Gomez-Bougie
,
Joy Le Coq
,
Cyrille Touzeau
,
et al.
Journal articles
inserm-01353369v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
BH3-profiling identifies heterogeneous dependency on Bcl-2 family members in Multiple Myeloma and predicts sensitivity to BH3 mimetics
Cyrille Touzeau
,
Jeremy Ryan
,
Jennifer L Guerriero
,
Philippe Moreau
,
Triona Ni Chonghaile
,
et al.
Journal articles
inserm-01411102v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.
Matthieu Hanf
,
David Chiron
,
Sophie de Visme
,
Cyrille Touzeau
,
Hervé Maisonneuve
,
et al.
Journal articles
hal-01524145v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)
Cyrille Touzeau
,
Steven Le Gouill
,
Béatrice Mahé
,
Jean-Samuel Boudreault
,
Thomas Gastinne
,
et al.
Journal articles
inserm-01445538v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
How I treat extramedullary myeloma
Cyrille Touzeau
,
Philippe Moreau
Journal articles
inserm-01411096v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
ABT-737 is highly effective against molecular subgroups of multiple myeloma
Linda Bodet
,
Patricia Gomez-Bougie
,
Cyrille Touzeau
,
Christelle Dousset
,
Géraldine Descamps
,
et al.
Journal articles
inserm-03290338v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|